Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.

Diseases

Genetic and Rare Diseases Information Center (GARD)

Print friendly version

X-linked lymphoproliferative syndrome


Other Names for this Disease

  • Duncan disease
  • EBV infection, severe, susceptibility to
  • EBVS
  • Epstein Barr virus infection, familial fatal
  • Lymphoproliferative disease, X-linked
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.

Overview

X-linked lymphoproliferative syndrome (XLP) is an immune system disorder that is found almost exclusively in males.  Individuals with XLP have an increased risk of infection because their body cannot properly regulate the number of immune system cells (lymphocytes) and blood cells.  Humans have two main types of lymphocytes, B cells and T cells, which work together to clear infections and keep the immune system in check. Individuals with XLP lack the proper regulation between B cells and T cells and are therefore unable to affectively destroy invading viruses, such as the usually harmless Epstein-Barr virus (EBV). Typically, XLP patients do not display severe symptoms of a compromised immune system until they have been exposed to EBV.  EBV infections, however, are common and can become life-threatening in people with XLP resulting in symptoms that  include fever, hepatitis, an enlarged spleen, abnormally low numbers of antibodies, and, in some cases, lymphoma and other blood disorders.  XLP is caused by mutations in the SH2D1A gene which makes a protein SAP, a key regulator in immunity, as well as the XIAP gene [1] XLP is inherited in an X-linked recessive pattern.[2][3]
Last updated: 5/6/2013

References

  1. Benowitz, Steve. NHGRI finds "off" switch that underlies rare genetic disease affecting boys. National Human Genome Research Institue. June 25, 2012; http://www.genome.gov/27549244. Accessed 6/27/2012.
  2. US National Library of Medicine. X-linked lymphoproliferative disease. Genetics Home Reference. August, 2010; http://ghr.nlm.nih.gov/condition/x-linked-lymphoproliferative-disease. Accessed 7/27/2012.
  3. Filipovich A. et al. Lymphoproliferative Disease, X-Linked. GeneReviews. November 10, 2011; http://www.ncbi.nlm.nih.gov/books/NBK1406/. Accessed 7/27/2012.
Your Questions Answered
by the Genetic and Rare Diseases Information Center

Please contact us with your questions about X-linked lymphoproliferative syndrome. We will answer your question and update these pages with new resources and information.

Basic Information

In Depth Information

  • Medscape Reference provides information on this topic. Click on the link to view this information. You may need to register to view the medical textbook, but registration is free.
  • Online Mendelian Inheritance in Man (OMIM) is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine. 
    OMIM: X-linked lymphoproliferative syndrome 1
    OMIM: X-linked lymphoproliferative syndrome 2
  • Orphanet is a European reference portal for information on rare diseases and orphan drugs.  Access to this database is free of charge.
  • PubMed is a searchable database of medical literature and lists journal articles that discuss X-linked lymphoproliferative syndrome. Click on the link to view a sample search on this topic.

Insurance Issues

Other Names for this Disease
  • Duncan disease
  • EBV infection, severe, susceptibility to
  • EBVS
  • Epstein Barr virus infection, familial fatal
  • Lymphoproliferative disease, X-linked
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.